Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.169,60
0,45%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ NexImmune Inc (NEXI) NexImmune Inc (NEXI) Notizie

NexImmune Inc

NEXI
3,32
0,20 (6,41%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/3/202419:20BWKonzernergebnis zum 31. Dezember 2023 genehmigt, starke..
07/3/202418:33BWApprobation des résultats financiers du groupe au 31..
07/3/202407:31BWApprovati i risultati finanziari di Gruppo al 31 dicembre..
07/3/202407:30BWGroup Financial Results as of December 31st 2023 Approved,..
06/2/202422:42GLOBENexImmune Announces Closing of $3.67 Million Registered..
06/2/202422:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05/2/202423:10EDGAR2Form 8-K - Current report
05/2/202422:34EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/2/202420:00GLOBENexImmune Announces $3.67 Million Registered Direct Offering..
02/2/202419:25EDGAR2Form 8-K - Current report
01/2/202415:17EDGAR2Form 8-K - Current report
19/1/202422:43EDGAR2Form 8-K - Current report
18/1/202422:43EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/12/202322:01EDGAR2Form 8-K - Current report
01/12/202319:39EDGAR2Form 8-K - Current report
22/11/202323:40EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
22/11/202323:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202322:39EDGAR2Form 144 - Report of proposed sale of securities
20/11/202323:19EDGAR2Form DEF 14A - Other definitive proxy statements
20/11/202323:01EDGAR2Form 8-K/A - Current report: [Amend]
17/11/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/11/202322:17EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
09/11/202323:47EDGAR2Form PRE 14A - Other preliminary proxy statements
09/11/202315:35BWFinanzergebnisse der Gruppe zum 30. September 2023..
09/11/202314:52BWLes résultats financiers du groupe au 30 septembre 2023 ont..
09/11/202307:30BWApprovati I Risultati Finanziari Di Gruppo Al 30 Settembre..
02/11/202322:12EDGAR2Form 8-K - Current report
02/11/202321:33EDGAR2Form 8-K - Current report
24/10/202314:00GLOBENexImmune, Yale, and JDRF Extend Research Partnership for..
19/10/202314:00GLOBENexImmune Announces Presentations at The Society for..
18/10/202322:15EDGAR2Form 8-K - Current report
18/10/202317:30GLOBENexImmune Announces 1-for-25 Reverse Stock Split
25/9/202322:42EDGAR2Form DEF 14A - Other definitive proxy statements
15/9/202322:06EDGAR2Form 8-K - Current report
13/9/202323:14EDGAR2Form PRE 14A - Other preliminary proxy statements
09/9/202301:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/8/202323:11EDGAR2Form 8-K - Current report
31/8/202322:45GLOBENexImmune Announces Workforce Reduction to Enable Continued..
10/8/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:06EDGAR2Form 8-K - Current report
10/8/202322:01GLOBENexImmune Reports Second Quarter 2023 Financial Results and..
02/8/202300:21BWFinanzergebnisse der Gruppe zum 30. Juni 2023 bestätigen..
01/8/202307:23BWGroup Financial Results as of June 30th 2023, Approved Solid..
07/7/202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202322:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202314:01GLOBENexImmune Presents Initial Positive Data from the NEXI-001..
22/5/202322:01GLOBENexImmune Announces Poster Presentation at the 2023 FOCIS..
15/5/202322:01GLOBENexImmune Reports First Quarter 2023 Financial Results and..
Apertura: 3,13 Min: 3,10 Max: 3,4899
Chiusura: 3,12

La tua Cronologia

NASDAQ
NEXI
NexImmune
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network